Case

Every successful collaboration is a testament to Yuxin Luchuang quality and strength. Explore how we provide reliable chemical solutions to customers in various industries worldwide, creating value together.

Technology Upgrade and Mass Production of Anti-tumor Pharmaceutical Intermediates

Time : 2025-01-13
Technology Upgrade and Mass Production of Anti-tumor Pharmaceutical Intermediates

To meet market demand for highly effective, low-toxic anti-tumor drugs, the company invested in R&D to upgrade the technology of a specific anti-tumor pharmaceutical intermediate. By optimizing the reaction route and improving the production process, the company not only reduced production costs by 30% but also controlled the product impurity content to below 0.1%. The technological upgrade enabled large-scale mass production, supplying 20 tons of high-quality anti-tumor pharmaceutical intermediates to downstream pharmaceutical companies monthly, helping to increase the production capacity of multiple anti-tumor drugs.